Summit Therapeutics Inc. Adjustments For Increase Decrease In Deferred Income
Summit Therapeutics Inc. (SMMT) reported Adjustments For Increase Decrease In Deferred Income of GBP 1.05 million for the 3-month period ending 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome · last filed 2020-06-02
- Summit Therapeutics Inc. adjustments for increase decrease in deferred income for the quarter ending 2020-03-31 was 1.05M GBP.
- Summit Therapeutics Inc. adjustments for increase decrease in deferred income for the quarter ending 2019-03-31 was -1.02M GBP.
- Summit Therapeutics Inc. adjustments for increase decrease in deferred income for the quarter ending 2018-07-31 was -35.18M GBP, a 382.03% decline year-over-year.
- Summit Therapeutics Inc. adjustments for increase decrease in deferred income for the quarter ending 2018-04-30 was -2.34M GBP.
| Period end | Adjustments For Increase Decrease In Deferred Income 3 month | Adjustments For Increase Decrease In Deferred Income 6 month | Adjustments For Increase Decrease In Deferred Income 11 month | Adjustments For Increase Decrease In Deferred Income 12 month | Adjustments For Increase Decrease In Deferred Income 12 month as first filed |
|---|---|---|---|---|---|
| 2020-03-31 | 1.05M GBP 6-K · filed 2020-06-02 | ||||
| 2019-12-31 | -2.70M GBP 20-F · filed 2020-04-30 | ||||
| 2019-03-31 | -1.02M GBP 6-K · filed 2020-06-02 | ||||
| 2019-01-31 | -36.90M GBP 20-F · filed 2020-04-30 | ||||
| 2018-07-31 | -35.18M GBP derived: 6-K 6 month − 6-K 3 month · filed 2018-09-20 | -37.52M GBP 6-K · filed 2018-09-20 | |||
| 2018-04-30 | -2.34M GBP 6-K · filed 2018-06-05 | ||||
| 2018-01-31 | 10.58M GBP 20-F · filed 2020-04-30 | -2.48M GBP 20-F · filed 2018-04-13 | |||
| 2017-07-31 | 12.47M GBP derived: 6-K 6 month − 6-K 3 month · filed 2018-09-20 | 10.75M GBP 6-K · filed 2018-09-20 | |||
| 2017-04-30 | -1.73M GBP 6-K · filed 2018-06-05 | ||||
| 2017-01-31 | 30.53M GBP 20-F · filed 2019-03-29 | ||||
| 2016-01-31 | 0.00 GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |